— Know what they know.
Not Investment Advice

GELS NASDAQ

Gelteq Limited Ordinary Shares
1W: -4.5% 1M: -25.5% 3M: -12.8% YTD: -37.8% 1Y: -59.6%
$0.52
-0.02 (-3.96%)
 
Weekly Expected Move ±20.8%
$0 $0 $1 $1 $1
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 43 · $4.8M mcap · 4M float · 115.02% daily turnover · Short 35% of daily vol

Balance Sheet Trends

Total Assets
$21M +3.5% ▲
5Y CAGR: +103.3%
Total Liabilities
$6M +0.4% ▲
5Y CAGR: +70.3%
Shareholders Equity
$16M +4.6% ▲
5Y CAGR: +134.5%
Cash & Investments
$345K +1305.5% ▲
5Y CAGR: +1.5%
Total Debt
$4M +9.7% ▲
5Y CAGR: +89.9%
Net Debt
$4M +1.4% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$182K$162K$399K$25K$345K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$182K$162K$399K$25K$345K
Net Receivables$193K$251K$345K$183K$460K
Inventory$0$95K$95K$0$0
Other Current Assets$0$99K$4K$16K$438K
Total Current Assets$375K$720K$991K$303K$2M
Property, Plant & Equip.$0$40K$10K$17K$16K
Goodwill & Intangibles$24M$23M$21M$20M$20M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$95K
Total Non-Current Assets$24M$23M$22M$20M$20M
Total Assets$24M$23M$22M$21M$21M
— Liabilities —
Accounts Payable$85K$217K$291K$387K$183K
Short-Term Debt$5K$5K$5K$2M$4M
Deferred Revenue$0$120K$85K$125K$0
Other Current Liabilities$7K$40K$78K$98K$856K
Total Current Liabilities$236K$1M$1M$4M$6M
Long-Term Debt$167K$1M$2M$2M$14K
Other Non-Current Liab.$0$0$0$20K$25K
Total Non-Current Liabilities$167K$1M$2M$2M$39K
Total Liabilities$403K$3M$4M$6M$6M
— Equity —
Common Stock$25M$25M$27M$27M$34M
Retained Earnings-$1M-$4M-$8M-$11M-$18M
Accumulated OCI$0$35K$0$0$0
Total Stockholders Equity$24M$21M$19M$15M$16M
Total Liabilities & Equity$24M$23M$22M$21M$21M
— Key Metrics —
Total Debt$172K$2M$2M$4M$4M
Net Debt-$10K$1M$2M$4M$4M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms